𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evolution of complement-fixing antibody titers with the development of burkitt's lymphoma

✍ Scribed by Roger Sohier; Guy De-Thé

Publisher
John Wiley and Sons
Year
1972
Tongue
French
Weight
358 KB
Volume
9
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Sera of 29 patients with Burkitt's lymphoma (BL) were studied at different stages of the disease process for complement‐fixing (CF) activities against a soluble antigen extracted from a leukaemia‐derived and virus‐producing lymphoblastoid line (QIMR‐WIL line of Pope). The CF antibody activity was low (with a geometric mean titre (GMT) of 12.35) in sera from patients with controlled tumour, and high (GMT of 38) in patients with advanced or progressive tumours. Furthermore, in seven cases, the CF litres decreased with the regression of the tumour, and in five cases, the CF titres increased in parallel with the progression of the disease. This situation recalls that observed in acute viral infections, where CF antibodies disappear rapidly once the infection is controlled. CF and EA (early antigen (s)) antibodies should be studied in parallel on the same sera as a possible means for establishing prognosis in BL patients.

📜 SIMILAR VOLUMES

Nasopharyngeal carcinoma. IV. Evolution
Nasopharyngeal carcinoma. IV. Evolution of complement-fixing antibodies during the course of the disease
✍ Guy De-Thé; Roger Sohier; John H. C. Ho; Robert Freund 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 French ⚖ 590 KB

## Abstract Sequential sera from 37 patients with nasopharyngeal carcinoma (NPC), with either controlled or uncontrolled tumours after radiotherapy, were studied for complement‐fixing (CF) antibodies against a soluble antigen extracted from the QIMR‐WIL lymphoblastoid line. When compared with resul

The spectrum of complement-fixing antinu
The spectrum of complement-fixing antinuclear antibodies in patients with hepatocellular carcinoma
✍ Kendo Kiyosawa; Richard J. Daemer; Li-Fang He; Ferruccio Bonino; O. W. Prozesky; 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 793 KB

Sera from 230 hepatocellular carcinoma patients were tested for antinuclear antibodies by anticomplement immunofluorescence in 16 types of transformed, diploid or primary cells of human, monkey, chimpanzee or rat origin. As controls, we tested 85 sera from patients with chronic liver diseases, 48 se

Comparison of the anti-ebv titer and the
Comparison of the anti-ebv titer and the ebv-associated membrane reactive and precipitating antibody levels in the sera of burkitt lymphoma and nasopharyngeal carcinoma patients and controls
✍ G. Klein; G. Geering; L. J. Old; G. Henle; W. Henle; P. Clifford 📂 Article 📅 1970 🏛 John Wiley and Sons 🌐 French ⚖ 763 KB

## Abstract Comparisons were made between 151 sera from 131 donors with Burkitt's lymphoma, nasopharyngeal carcinoma and other tumors of the head and neck area, from patients having had infectious mononucleosis and from healthy controls, in three EBV‐associated serological tests: intracellular immu

Reactivity with patient antibodies of pa
Reactivity with patient antibodies of partially purified gp40 antigen from immune complexes in burkitt's lymphoma and nasopharyngeal carcinoma
✍ Y. Gazitt; G. Klein; D. Sultzeanu 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 French ⚖ 691 KB

## Abstract A glycoprotein antigen (gp40) was previously identified as a major component of immune complexes isolated from sera of patients with Burkitt's lymphoma (BL) and nasopharyngeal carcinoma (NPC). In the present work gp40 was partially purified from a pool of BL/NPC sera. Sera of patients w